FDA NDC Directory · JSON-LD · Markdown

Sodium Polystyrene Sulfonate

NDC 46287-012 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerCMP Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA089910
Dosage form / routePOWDER, FOR SUSPENSION · ORAL RECTAL
Active ingredientsSODIUM POLYSTYRENE SULFONATE (1 g/g)
Marketing started19890119
Package count1

External sources

Source: openFDA. Public-domain (CC0).